Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
20vPnC Lot Consistency and Safety in Adults 18-49
NCT03828617Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2019
- Primary completion
- Oct 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Prevnar 20 in pneumococcal disease, sponsored by Pfizer. Started Feb 2019; status: completed.
02
Drugs
Prevnar 20
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT03828617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03828617.